Page 1 of 1

Table 3. Average Monthly Medicaid Payments for HIV Patients by Protease Inhibitor Use

Research in Action, Issue 8

CD4 cell count and cost19961997
No protease inhibitor useProtease inhibitor useNo protease inhibitor useProtease inhibitor use
CD4 cell count less than 50 x 106Pharmacy cost$487$852$508$745
Total average cost$2,047$1,704$2,805$1,814
CD4 cell count 50-200 x 106Pharmacy cost$390$663$398$763
Total average cost$1,515$1,123$1,495$1,623
CD4 cell count 200-500 x 106Pharmacy cost$267$455$299$652
Total average cost$1,036$780$1,395$1,031

Note: Total average cost includes inpatient, outpatient, pharmacy, community care, and emergency room costs.

Source: Gebo KA, Chaisson RE, Folkemer JG, et al. Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS 1999; 13(8):963-9.

Return to Document

Current as of September 2002
Internet Citation: Table 3. Average Monthly Medicaid Payments for HIV Patients by Protease Inhibitor Use: Research in Action, Issue 8. September 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/factsheets/pharmaceutical/rxtherapies/rxriatab3.html